Mr Or Levi
(Israel)
BA6b9, a novel sk4 K + channel blocker, attenuates atrial fibrillation substrate in rats with reduced ejection fraction
Event: ESC Congress 2024
Topic: Antiarrhythmic Drug Treatment
Session: Clinical and experimental arrhythmia treatments
